Completed
Phase I Study to Assess the Safety and Immunology of a COVID-19 Vaccine With GRAd-COV2 Vaccine
NCT04528641
- Conditions
- COVID-19, Coronaviridae Infections, Coronavirus Infections, +9 more
- Locations
-
- INMI Spallanzani Rome, Italy
- Centro Ricerche Cliniche Verona, Italy